Low-Dose Naltrexone (LDN)
One-Day Virtual Conference

Summary

Individuals who suffer from symptoms of gastrointestinal, autoimmune, dermatological and pain conditions make up 80% of the patient population. The good news? Low-dose naltrexone (LDN) has been studied recently in many conditions.

This one-day virtual conference will provide insight into the science, physiology and mechanisms of action of LDN, and answer your questions about the many conditions it may be beneficial for, including:

• GI disorders
• Hashimoto’s thyroiditis
• Arthritis
• Fibromyalgia
• Migraines
• Chronic pain management
• Inflammatory conditions of the skin
• And so much more

Plus, you’ll learn about the quality of our compounded medication ingredients and procedures.

Registration includes:

• Educational materials available via app
• Video recording available for viewing for 60 days
• Eligible for ACPE credit for pharmacists and technicians

Pricing

Agenda

d>

Thursday, November 21	All Times Listed in Central Time (CT).
9:00 AM	Opening Announcements
9:10 AM	Introduction to LDN (CE) – Sebastian Denison, RPh
9:30 AM	The Immune System, Autoimmune Conditions and the Benefits of LDN – Catherine Henderson, PharmD
10:10 AM	Break
10:20 AM	Dermatological Inflammatory Diseases and LDN – Nat Jones, RPh, FAPC
11:10 AM	The Use of LDN in Veterinary Patients – Katy Hecker, PharmD
11:30 AM	Break
11:40 AM	Perimenopause and Menopause Is an Inflammatory Condition: The Use of LDN for Hormones and Weight Loss – Sara Hover, RPh, FAARM
12:15 PM	Break
12:45 PM	Using LDN for Chronic Pain Conditions – Tricia Heitman, PharmD
1:15 PM	Can LDN Be Used in Oncology? – Matt Lester, RPh, MBA
1:45 PM	Break
1:55 PM	LDN for Gut Inflammatory Disorders – Ranel Larsen, PharmD
2:30 PM	Dosing Guidelines and Protocols with LDN – Sebastian Denison, RPh
2:50 PM	How to Market LDN Studies – Mark Gonzalez, PharmD
3:05 PM	Q&A with Sebastian Denison, RPh
3:25 PM	Closing Announcements
3:30 PM	Adjourn

Speakers